| Literature DB >> 23640362 |
Jessica Nicastro1, Katlyn Sheldon, Farah A El-Zarkout, Stanislav Sokolenko, Marc G Aucoin, Roderick Slavcev.
Abstract
The Bacteriophage λ capsid protein gpD has been used extensively for fusion polypeptides that can be expressed from plasmids in Escherichia coli and remain soluble. In this study, a genetically controlled dual expression system for the display of enhanced green fluorescent protein (eGFP) was developed and characterized. Wild-type D protein (gpD) expression is encoded by λ Dam15 infecting phage particles, which can only produce a functional gpD protein when translated in amber suppressor strains of E. coli in the absence of complementing gpD from a plasmid. However, the isogenic suppressors vary dramatically in their ability to restore functional packaging to λDam15, imparting the first dimension of decorative control. In combination, the D-fusion protein, gpD::eGFP, was supplied in trans from a multicopy temperature-inducible expression plasmid, influencing D::eGFP expression and hence the availability of gpD::eGFP to complement for the Dam15 mutation and decorate viable phage progeny. Despite being the worst suppressor, maximal incorporation of gpD::eGFP into the λDam15 phage capsid was imparted by the SupD strain, conferring a gpDQ68S substitution, induced for plasmid expression of pD::eGFP. Differences in size, fluorescence and absolute protein decoration between phage preparations could be achieved by varying the temperature of and the suppressor host carrying the pD::eGFP plasmid. The effective preparation with these two variables provides a simple means by which to manage fusion decoration on the surface of phage λ.Entities:
Mesh:
Substances:
Year: 2013 PMID: 23640362 PMCID: PMC3745828 DOI: 10.1007/s00253-013-4898-6
Source DB: PubMed Journal: Appl Microbiol Biotechnol ISSN: 0175-7598 Impact factor: 4.813
Bacteria, phage and plasmids
| Cell/phage/plasmid designation | Genotype | Source/reference |
|---|---|---|
| Bacterial strains | ||
| BB4 |
| Agilent Technologies, Inc. |
| DS-3 | F−, | CGSC# 4604 |
| Hoffman and Wilhelm ( | ||
| W3899 | F−, | CGSC# 5177 |
| Edlin and Sundaram ( | ||
| K1227 | F−, | CGSC# 7058 |
| CAG12077 | F−, | CGSC# 7347 |
| Grossman et al. ( | ||
| Nichols et al. ( | ||
| CAG12156 | F−, λ−, | CGSC# 7394 |
| Grossman et al. ( | ||
| W3101 | F−, | CGSC #4467 |
| Bachmann ( | ||
| W3101 SupD | F−, | This study |
| W3101 SupE | F−, | This study |
| W3101 SupF | F−, | This study |
| Phage strains | ||
| λ | λ | Windass and Brammar ( |
| λF7 | λ | Mikawa et al. ( |
| Plasmids | ||
| pPL451 |
| National BioResource Project (NBRP); |
| pPL451 gpD |
| Sokolenko et al. ( |
| pPL451 gpD::eGFP |
| Sokolenko et al. ( |
Variable amber suppression and complementation of the Dam15 mutation
| Straina/plasmidb | Relative efficiency of plating (eop)c | ||||
|---|---|---|---|---|---|
| 30 °C | 32–33 °C | 35 °C | 37 °C | 39–40 °C | |
| Sup− | nd | nd | nd | 1.92 × 10−6 | nd |
| pD− | 4.06 × 10−6 | 5.0 × 10−6 | 3.1× 10−6 | 1.7 × 10−6 | 2.0 × 10−6 |
| pD+ | 7.5 × 10−6 | 3.2 × 10−5 | 2.1 × 10−4 | 0.15 | 0.93 |
| pD::eGFP | 7.5 × 10−6 | 2.0 × 10−5 | 2.0 × 10−5 | 0.02 | 0.01 |
| SupD | nd | nd | nd | 1.13 × 10−5 | nd |
| pD− | 8.8 × 10−5 | 6.5 × 10−5 | 1.5 × 10−5 | 9.5 × 10−6 | 2.3 × 10−5 |
| pD::eGFP | 4.9 × 10−5 | 1.8 × 10−5 | 8.0 × 10−5 | 0.09 | 0.05 |
| SupE | nd | nd | nd | 0.09 | nd |
| pD− | 0.04 | 0.11 | 0.07 | 0.03 | 0.08 |
| pD::eGFP | 0.1 | 0.04 | 0.02 | 0.07 | 0.03 |
| SupF | nd | nd | nd | 0.19 | nd |
| pD− | 0.01 | 0.01 | 0.04 | 0.04 | 0.03 |
| pD::eGFP | 0.1 | 0.13 | 0.06 | 0.07 | 0.05 |
aDerivatives are W3101 background
bDerivatives of CI857 temperature-regulated expression plasmid pPL451
cAll efficiency of plating (eop) determinations from a minimum of three assays and determined using BB4 (SupE, SupF) as the 100 % control
Estimated average eGFP molecules per phage
| Strain (+/− plasmid)a | Estimated eGFP/phageb,c | |||
|---|---|---|---|---|
| 30 °C | 35 °C | 37 °C | 39 °C | |
| Sup− [pD::eGFP] | n/a | 44 ± 4.22 | 115 ± 4.39 | 61 ± 4.16 |
| SupD [pD::eGFP] | 86 ± 4.20 | 127 ± 4.16 | 147 ± 4.18 | 142 ± 4.17 |
| SupE [pD::eGFP] | 46 ± 4.26 | 53 ± 4.34 | 77 ± 4.22 | 69 ± 4.25 |
| SupF [pD::eGFP] | 65 ± 4.27 | 69 ± 4.25 | 89 ± 4.19 | 69 ± 4.44 |
aAll strains are derivatives of W3101
bFluorescence measurements were divided by those derived from the 100 % control grown on the double suppressor λF7. Values in parentheses denote calculated number of functional eGFP fusions per phage interpolated from eGFP purified protein fluorescence calibration curve
cPhage preparation on W3101[pD] at 37 °C expressing gpDwt in trans
Sizing of λ Dam15 phage variably decorated by gpD::eGFP
| Strain [+ plasmid]a | gpD Allele | Times (X) increase in phage diameterb,c | |||
|---|---|---|---|---|---|
| 30 °C | 35 °C | 37 °C | 39 °C | ||
| Sup− | gpDwt | nd | nd | 1.1 ± 0.2 | nd |
| Sup− [pD::eGFP] | n/a | 2.2 ± 0.5 | 5.5 ± 0.8 | 3.5 ± 0.9 | |
| SupD | gpDwt | nd | nd | 0.3 ± 0.03 | nd |
| SupD [pD::eGFP] | 0.8 ± 0.1 | 1.2 ± 0.7 | 3.1 ± 1.5 | 1.8 ± 0.2 | |
| SupE | gpDQ68S | nd | nd | 1.0 ± 0.1 | nd |
| SupE [pD::eGFP] | 0.9 ± 0.2 | 1.0 ± 0.1 | 1.7 ± 0.2 | 1.2 ± 0.2 | |
| SupF | gpDQ68Y | nd | nd | 0.67 ± 0.3 | nd |
| SupF [pD::eGFP] | 1.0 ± 0.3 | 1.3 ± 0.2 | 1.6 ± 0.6 | 1.0 ± 0.3 | |
aLysate produced on strain at respective temperature. All strains are derivatives of W3101
bA minimum of three runs of triplicate determinations of size determination from DLS were divided by size determinations for naked phage grown on each of the Sup strains. Comparisons are for phage grown on SupE in absence of complementation
cPhage preparation on W3101[pD] at 37 °C expressing gpDwt in trans
Fig. 1Mean fluorescent event counts for phage preparations on Sup−, SupD, SupE and SupF strains carrying pD::eGFP, cultured at 30, 35, 37, and 39 °C. Samples were standardized for titre and diluted tenfold with PBS to avoid coincidence. Fluorescent events are those that had a fluorescence value greater than 1 (the logarithmic scale equivalent of 0). Error bars represent 95 % confidence intervals around the means, calculated from triplicate measurements. In most cases, the error bars are smaller than the size of the corresponding data point
Fig. 22D density distribution of fluorescence versus side scatter for phage preparations on Sup−, SupD, SupE and SupF strains carrying pD::eGFP, cultured at 30, 35, 37, and 39 °C. The density distribution at each temperature is scaled to a constant height. Contour lines represent fractions of maximum density (density quantiles ranging from 0.10 to 0.80 in intervals of 0.10 and 0.80 to 0.95 in intervals of 0.05). Events with fluorescence or side scatter values of 1 were excluded. Samples were standardized for titre. SupD and Sup− samples cultured at 37 °C had high concentrations that resulted in a considerable amount of coincidence. The contours corresponding to these samples were calculated from samples diluted 10 fold with PBS; all other contours were calculated from undiluted samples to avoid excessive noise
Fig. 3Immunoblot of eGFP species from decorated phage. (A) Phage preparations were standardized for titer and immunoblotted with anti-eGFP. Lane 1 size markers; Lane 2 λimm21Dam15 phage grown on W3101 [pD::eGFP] at 40 °C; Lane 3 λimm21Dam15 phage grown on W3101 supD [pD::eGFP] at 40 °C; Lane 4 λ imm21Dam15 phage grown on W3101 [pD] at 40 °C. (B) eGFP protein standards: 50, 10, 1 ng, respectively
Variable susceptibility to EDTA exposure of λ Dam15 phage
| Strain [+ Plasmid]a | Relative efficiency of plating (eop)b,c |
|---|---|
| Sup− [pD] | 0.93 |
| Sup− [pD::eGFP] | 0.36 |
| SupD [pD]− | 0.35 |
| SupD [pD::eGFP] | 0.59 |
| SupE [pD]− | 0.91 |
| SupE [pD::eGFP] | 0.54 |
| SupF [pD]− | 0.44 |
| SupF [pD::eGFP] | 0.57 |
aLysate produced on strain at 37 °C. All strains are derivatives of W3101
bCalculated from a minimum of three determinations grown on BB4 (SupE, SupF)
cAll efficiency of plating (eop) determinations from a minimum of three assays and using the original universal determined concentration of 4.00 × 108 grown on BB4 (SupE, SupF) as the 100 % control
Fig. 4Separation of decorated phage preparations based on fluorescence emitted and size as determined by DLS. Fluorescence and size ratios based on comparison to λF7 grown on W3101 supE [pD::eGFP]. The measured sizes are reported using a % intensity distribution. Each data point was automatically repeated in triplicate, and the average is reported. Sizing results are expressed based on “x” increase compared to wild-type, which is λimm21Dam15 (λF7) grown on the BB4 providing gpDwt incorporation into the resultant phage capsid. Measured fluorescence data was analyzed using the SoftMaxPro V5 software based on six readings and the samples were run in duplicate with the average being reported. Phage samples were run alongside an eGFP standard to determine the protein concentrations of each sample. Phage fluorescence for each preparation derivative was interpolated from the trend-line for known eGFP concentrations